Related references
Note: Only part of the references are listed.Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives
Lorena Lorefice et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2023)
Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset
Susana Otero-Romero et al.
EUROPEAN JOURNAL OF NEUROLOGY (2022)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
INTERNATIONAL JOURNAL OF SURGERY (2021)
Effect of Vitamin D Supplements on Relapse Rate and Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
Sara Hanaei et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2021)
Menopause in women with multiple sclerosis: A systematic review
Vasilios Karageorgiou et al.
MATURITAS (2020)
Relapsing and progressive MS: the sex-specific perspective
Paulus Stefan Rommer et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Sex effects across the lifespan in women with multiple sclerosis
Kristen M. Krysko et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Impact of sex hormones on immune function and multiple sclerosis development
Maria C. Ysrraelit et al.
IMMUNOLOGY (2019)
Sex differences in immunity INTRODUCTION
Hanna Lotter et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Impact of natural menopause on multiple sclerosis: a multicentre study
Damiano Baroncini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis
Amirreza Azimi et al.
BMC NEUROLOGY (2019)
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
Alessandro Maglione et al.
CELLS (2019)
Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers
Bart G. Jones et al.
INTERNATIONAL IMMUNOLOGY (2019)
The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review
Mahsa Ghajarzadeh et al.
JMIR RESEARCH PROTOCOLS (2019)
Ovarian aging is associated with gray matter volume and disability in women with MS
Jennifer S. Graves et al.
NEUROLOGY (2018)
The Influence of Menopause in Multiple Sclerosis Course: A Longitudinal Cohort Study
Filipa Ladeira et al.
EUROPEAN NEUROLOGY (2018)
Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function
Klaus Lehmann-Horn et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Validity and Reliability of the Persian Version of the PERception de la Scle'rose En Plaques et de ses Pousse'es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life
Mahsa Ghajarzadeh et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2016)
Hormonal and gender-related immune changes in multiple sclerosis
L. Airas
ACTA NEUROLOGICA SCANDINAVICA (2015)
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
Karen Ann Ribbons et al.
PLOS ONE (2015)
Non-feminizing estrogens: A novel neuroprotective therapy
Ashley B. Petrone et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Role of puberty in multiple sclerosis risk and course
Tanuja Chitnis
CLINICAL IMMUNOLOGY (2013)
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
Nicolas Molnarfi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Biomarkers of Ovarian Reserve-Do They Predict Somatic Aging?
Marcelle I. Cedars
SEMINARS IN REPRODUCTIVE MEDICINE (2013)
Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration
Rory D. Spence et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
Differential Roles of Estrogen Receptors α and β in Control of B-Cell Maturation and Selection
Latia Hill et al.
MOLECULAR MEDICINE (2011)
The changing demographic pattern of multiple sclerosis epidemiology
Nils Koch-Henriksen et al.
LANCET NEUROLOGY (2010)
Assessing changes in relapse rates in multiple sclerosis
Seidu Inusah et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Menopause and aging Changes in the immune system-A review
Catia Morgado Gameiro et al.
MATURITAS (2010)
Age of puberty and the risk of multiple sclerosis: a population based study
S. V. Ramagopalan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice
Seema Tiwari-Woodruff et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Estrogens directly potentiate neuronal L-type Ca2+ channels
Saumyendra N. Sarkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparison of in vivo and in vitro subcellular localization of estrogen receptors α and β in oligodendrocytes
Z Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2004)
17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death
T Takao et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study
G Berg et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2002)
Age-related disability in multiple sclerosis
M Trojano et al.
ANNALS OF NEUROLOGY (2002)
Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients
Z Liang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis
M Filippi et al.
NEUROLOGY (2001)
Share Paper
